Suppr超能文献

[新型H1抗组胺药阿司咪唑治疗荨麻疹——特别提及起效时间和最大效应时间]

[Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].

作者信息

Kurz K

出版信息

Z Hautkr. 1986 Nov 15;61(22):1646-53.

PMID:2880431
Abstract

20 patients, 12 suffering from chronic urticaria, 2 from acute urticaria, 1 from pressure urticaria, 2 from cold urticaria and 3 from urticaria factitia were treated in an open pilot study with the new H1-antihistamine Astemizole. The dosage was in all cases 1 X 10 mg per day. The onset of action as well as the efficacy maximum were registered. Astemizole proved in this study to be a very effective antihistamine being able to achieve good results even in hard to cure cases like cold urticaria. On the 1. day 35% of the patients had noticed an onset of action. 75% of the patients had an onset of action within the first 2 days. The efficacy maximum was achieved within the first 2 days in 60% of the patients.

摘要

在一项开放性初步研究中,使用新型H1抗组胺药阿司咪唑对20例患者进行了治疗,其中12例患有慢性荨麻疹,2例患有急性荨麻疹,1例患有压力性荨麻疹,2例患有寒冷性荨麻疹,3例患有人工性荨麻疹。所有病例的剂量均为每日1次,每次10毫克。记录了起效时间以及最大疗效。在这项研究中,阿司咪唑被证明是一种非常有效的抗组胺药,即使在像寒冷性荨麻疹这样难以治愈的病例中也能取得良好效果。在第1天,35%的患者注意到有起效。75%的患者在头2天内起效。60%的患者在头2天内达到最大疗效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验